Challenges Enrolling Children Into Traumatic Brain Injury Trials: An Observational Study
dc.contributor.author | Stanley, Rachel M. | |
dc.contributor.author | Johnson, Michael D. | |
dc.contributor.author | Vance, Cheryl | |
dc.contributor.author | Bajaj, Lalit | |
dc.contributor.author | Babcock, Lynn | |
dc.contributor.author | Atabaki, Shireen | |
dc.contributor.author | Thomas, Danny | |
dc.contributor.author | Simon, Harold K. | |
dc.contributor.author | Cohen, Daniel M. | |
dc.contributor.author | Rubacalva, Daniel | |
dc.contributor.author | David Adelson, P. | |
dc.contributor.author | Bulloch, Blake | |
dc.contributor.author | Rogers, Alexander J. | |
dc.contributor.author | Mahajan, Prashant | |
dc.contributor.author | Baren, Jill | |
dc.contributor.author | Lee, Lois | |
dc.contributor.author | Hoyle, John | |
dc.contributor.author | Quayle, Kimberly | |
dc.contributor.author | Charles Casper, T. | |
dc.contributor.author | Michael Dean, J. | |
dc.contributor.author | Kuppermann, Nathan | |
dc.contributor.author | Panagos, Peter D. | |
dc.date.accessioned | 2017-02-02T22:01:09Z | |
dc.date.available | 2018-03-01T16:43:51Z | en |
dc.date.issued | 2017-01 | |
dc.identifier.citation | Stanley, Rachel M.; Johnson, Michael D.; Vance, Cheryl; Bajaj, Lalit; Babcock, Lynn; Atabaki, Shireen; Thomas, Danny; Simon, Harold K.; Cohen, Daniel M.; Rubacalva, Daniel; David Adelson, P.; Bulloch, Blake; Rogers, Alexander J.; Mahajan, Prashant; Baren, Jill; Lee, Lois; Hoyle, John; Quayle, Kimberly; Charles Casper, T.; Michael Dean, J.; Kuppermann, Nathan; Panagos, Peter D. (2017). "Challenges Enrolling Children Into Traumatic Brain Injury Trials: An Observational Study." Academic Emergency Medicine (1): 31-39. | |
dc.identifier.issn | 1069-6563 | |
dc.identifier.issn | 1553-2712 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/135996 | |
dc.description.abstract | ObjectivesIn preparation for a clinical trial of therapeutic agents for children with moderate‐to‐severe blunt traumatic brain injuries (TBIs) in emergency departments (EDs), we conducted this feasibility study to (1) determine the number and clinical characteristics of eligible children, (2) determine the timing of patient and guardian arrival to the ED, and (3) describe the heterogeneity of TBIs on computed tomography (CT) scans.MethodsWe conducted a prospective observational study at 16 EDs of children ≤ 18 years of age presenting with blunt head trauma and Glasgow Coma Scale scores of 3–12. We documented the number of potentially eligible patients, timing of patient and guardian arrival, patient demographics and clinical characteristics, severity of injuries, and cranial CT findings.ResultsWe enrolled 295 eligible children at the 16 sites over 6 consecutive months. Cardiac arrest and nonsurvivable injuries were the most common characteristics that would exclude patients from a future trial. Most children arrived within 2 hours of injury, but most guardians did not arrive until 2–3 hours after the injury. There was a substantial range in types of TBIs, with subdural hemorrhages being the most common.ConclusionEnrolling children with moderate‐to‐severe TBI into time‐sensitive clinical trials will require large numbers of sites and meticulous preparation and coordination and will prove challenging to obtain informed consent given the timing of patient and guardian arrival. The Federal Exception from Informed Consent for Emergency Research will be an important consideration for enrolling these children. | |
dc.publisher | U.S. Department of Health and Human Services, Centers for Disease Control and Prevention | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.title | Challenges Enrolling Children Into Traumatic Brain Injury Trials: An Observational Study | |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Medicine (General) | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/135996/1/acem13085_am.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/135996/2/acem13085.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/135996/3/acem13085-sup-0001-DataSupplementS1.pdf | |
dc.identifier.doi | 10.1111/acem.13085 | |
dc.identifier.source | Academic Emergency Medicine | |
dc.identifier.citedreference | Badaki‐Makun O, Scott JP, Panepinto JA, et al. Intravenous magnesium for pediatric sickle cell vaso‐occlusive crisis: methodological issues of a randomized controlled trial. Pediatric Blood Cancer 2014; 61: 1049 – 54. | |
dc.identifier.citedreference | Schneier AJ, Shields BJ, Hostetler SG, Xiang H, Smith GA. Incidence of pediatric traumatic brain injury and associated hospital resource utilization in the United States. Pediatrics 2006; 118: 483 – 92. | |
dc.identifier.citedreference | Center for Disease Control and Prevention. Rates of TBI‐related Deaths by Age Group – United States, 2001–2010. Available at: http://www.cdc.gov/traumaticbraininjury/data/rates_deaths_byage.html. Accessed Aug 19, 2016. | |
dc.identifier.citedreference | Centers for Disease Control and Prevention. Get the Stats on Traumatic Brain Injury in the United States. Available at: http://www.cdc.gov/traumaticbraininjury/pdf/bluebook_factsheet-a.pdf. Accessed Aug 19, 2016. | |
dc.identifier.citedreference | Natale JE, Joseph JG, Pretzlaff RK, Silber TJ, Guerguerian AM. Clinical trials in pediatric traumatic brain injury: unique challenges and potential responses. Dev Neurosci 2006; 28: 276 – 90. | |
dc.identifier.citedreference | Narayan RK, Michel ME, Ansell B, et al. Clinical trials in head injury. J Neurotrauma 2002; 19: 503 – 57. | |
dc.identifier.citedreference | Menon DK. Unique challenges in clinical trials in traumatic brain injury. Crit Care Med 2009; 37 ( 1 Suppl ): S129 – 35. | |
dc.identifier.citedreference | Adelson PD, Wisniewski SR, Beca J, et al. Comparison of hypothermia and normothermia after severe traumatic brain injury in children (Cool Kids): a phase 3, randomised controlled trial. Lancet Neurol 2013; 12: 546 – 53. | |
dc.identifier.citedreference | Holmes JF, Holubkov R, Kuppermann N. Guardian availability in children evaluated in the emergency department for blunt head trauma. Acad Emerg Med 2009; 16: 15 – 20. | |
dc.identifier.citedreference | Food and Drug Administration. Guidance for Institutional Review Boards, Clinical Investigators and Sponsors: Exception from Informed Consent Requirements for Emergency Medicine Research. March 2011. Available at: http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM249673.pdf. Accessed Jan 6, 2015. | |
dc.identifier.citedreference | Code of Federal Regulations Title 21: Exception from Informed Consent Requirements for Emergency Research. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=50.24. Accessed Aug 19, 2016. | |
dc.identifier.citedreference | CRASH 3‐Clinical Randomisation of an Antifibrolytic in Significant Head Injury. Available at: http://crash3.lshtm.ac.uk/. Accessed Aug 10, 2016. | |
dc.identifier.citedreference | Dewan Y, Komolafe EO, Mejia‐Mantilla JH, et al. CRASH‐3 ‐ tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double‐blind, placebo‐controlled trial. Trials 2012; 13: 87. | |
dc.identifier.citedreference | World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013; 310: 2191 – 4. | |
dc.identifier.citedreference | Wright DW, Yeatts SD, Silbergleit R, et al. Very early administration of progesterone for acute traumatic brain injury. N Engl J Med 2014; 371: 2457 – 66. | |
dc.identifier.citedreference | Skolnick BE, Maas AI, Narayan RK, et al. A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med 2014; 371: 2467 – 76. | |
dc.identifier.citedreference | Stanley RM, Bonsu BK, Zhao W, Ehrlich PF, Rogers AJ, Xiang H. US estimates of hospitalized children with severe traumatic brain injury: implications for clinical trials. Pediatrics 2012; 129: e24 – 30. | |
dc.identifier.citedreference | Kuppermann N, Holmes JF, Dayan PS, et al. Identification of children at very low risk of clinically‐important brain injuries after head trauma: a prospective cohort study. Lancet 2009; 374: 1160 – 70. | |
dc.identifier.citedreference | Moler FW, Donaldson AE, Meert K, et al. Multicenter cohort study of out‐of‐hospital pediatric cardiac arrest. Crit Care Med 2011; 39: 141 – 9. | |
dc.identifier.citedreference | Chamberlain JM, Okada P, Holsti M, et al. Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial. JAMA 2014; 311: 1652 – 60. | |
dc.identifier.citedreference | Holmes JF, Lillis K, Monroe D, Borgialli D, Kerrey BT, Mahajan P, Adelgais K, Ellison AM, Yen K, Atabaki S, Menaker J, Bonsu B, Quayle KS, Garcia M, Rogers A, Blumberg S, Lee L, Tunik M, Kooistra J, Kwok M, Cook LJ, Dean JM, Sokolove PE, Wisner DH, Ehrlich P, Cooper A, Dayan PS, Wootton‐Gorges S, Kuppermann N. Pediatric Emergency Care Applied Research Network (PECARN). Ann Emerg Med. 2013; 62: 107–116. e2. | |
dc.identifier.citedreference | Moler FW, Silverstein FS, Holubkov R, et al. Therapeutic hypothermia after out‐of‐hospital cardiac arrest in children. N Engl J Med 2015; 372: 1898 – 908. | |
dc.identifier.citedreference | Tzimenatos L, Kim E, Kuppermann N. The Pediatric Emergency Care Applied Research Network: a history of multicenter collaboration in the United States. Pediatr Emerg Care 2015; 31: 70 – 6. | |
dc.identifier.citedreference | Corneli HM, Zorc JJ, Mahajan P, et al. A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med 2007; 357: 331 – 9. | |
dc.identifier.citedreference | Stanley R. EMSC Targeted Issues Grant Funding: Progesterone for Traumatic Brain Injury in Children: Planning a Safety and Efficacy Trial. Available at: http://www.emscresources.org/historicalgrants/searchResults.php?stateSearch=MI. Accessed at: Jun 12, 2015. | |
dc.identifier.citedreference | Vavilala MS, Bowen A, Lam AM, et al. Blood pressure and outcome after severe pediatric traumatic brain injury. J Trauma 2003; 55: 1039 – 44. | |
dc.identifier.citedreference | Kochanek PM, Carney N, Adelson PD, et al. Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents–second edition. Pediatr Crit Care Med 2012; 13 ( Suppl 1 ): S1 – 82. | |
dc.identifier.citedreference | Van Cleve W, Kernic MA, Ellenbogen RG, et al. National variability in intracranial pressure monitoring and craniotomy for children with moderate to severe traumatic brain injury. Neurosurgery 2013; 73: 746 – 52; discussion 752; quiz 752. | |
dc.identifier.citedreference | The Established Status Epilepticus Treatment Trial. Available at: http://nett.umich.edu/clinical-trials/esett. Accessed Aug 19, 2016. | |
dc.identifier.citedreference | Maas AI, Roozenbeek B, Manley GT. Clinical trials in traumatic brain injury: past experience and current developments. Neurotherapeutics 2010; 7: 115 – 26. | |
dc.identifier.citedreference | Roberts I, Yates D, Sandercock P, et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo‐controlled trial. Lancet 2004; 364: 1321 – 8. | |
dc.identifier.citedreference | Pusateri AE, Weiskopf RB, Bebarta V, et al. Tranexamic acid and trauma: current status and knowledge gaps with recommended research priorities. Shock 2013; 39: 121 – 6. | |
dc.identifier.citedreference | Yutthakasemsunt S, Kittiwatanagul W, Piyavechvirat P, Thinkamrop B, Phuenpathom N, Lumbiganon P. Tranexamic acid for patients with traumatic brain injury: a randomized, double‐blinded, placebo‐controlled trial. BMC Emerg Med 2013; 13: 20. | |
dc.identifier.citedreference | Crash‐2 Collaborators, Intracranial Bleeding Study. Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH‐2 Intracranial Bleeding Study). BMJ 2011; 343: d3795. | |
dc.identifier.citedreference | Beno S, Ackery AD, Callum J, Rizoli S. Tranexamic acid in pediatric trauma: why not? Crit Care 2014; 18: 313. | |
dc.identifier.citedreference | Nishijima DK, Monuteaux MC, Faraoni D, et al. Tranexamic acid use in United States children’s hospitals. J Emerg Med 2016; 50 868 – 74.e1. | |
dc.identifier.citedreference | Faul M, Xu L, Wald MM, Coronado VG. Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations, and Deaths 2002–2006. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2010. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.